All Pharma News
Adverum Presents LUNA 26-Week Interim Analysis at ASRS

Adverum Presents LUNA 26-Week Interim Analysis at ASRS
GLOBENEWSWIRE
25 Apr 2024
Share Share
Adverum Biotechnologies Reports4Q FYR 2023 & Provides Pipeline Highlights

Adverum Biotechnologies Reports4Q FYR 2023 & Provides Pipeline Highlights
GLOBENEWSWIRE
18 Mar 2024
Share Share
Adverum Reports Fourth Quarter and Full Year 2023 Financial Results

Adverum Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
18 Mar 2024
Share Share
Adverum Bio to Participate in the TD Cowen 44th Annual Health Care Conference

Adverum Bio to Participate in the TD Cowen 44th Annual Health Care Conference
GLOBENEWSWIRE
28 Feb 2024
Share Share
Adverum to Participate in the Oppenheimer 34th Annual Life Sciences Conference

Adverum to Participate in the Oppenheimer 34th Annual Life Sciences Conference
GLOBENEWSWIRE
12 Feb 2024
Share Share
Adverum Announces Positive Safety Data from LUNA Phase 2 Trial of Ixo-vec

Adverum Announces Positive Safety Data from LUNA Phase 2 Trial of Ixo-vec
GLOBENEWSWIRE
08 Feb 2024
Share Share
Adverum`s gene therapy reduces treatment burden in wet AMD

Adverum`s gene therapy reduces treatment burden in wet AMD
Gabrielle Masson FIERCE BIOTECH
08 Feb 2024
Share Share
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
GLOBENEWSWIRE
05 Feb 2024
Share Share
Adverum will Host Webcast to Review LUNA Phase 2 Efficacy and Safety Results

Adverum will Host Webcast to Review LUNA Phase 2 Efficacy and Safety Results
GLOBENEWSWIRE
01 Feb 2024
Share Share
Adverum Bio Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer

Adverum Bio Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
GLOBENEWSWIRE
29 Jan 2024
Share Share